MA01.05 Clinical Efficacy and Safety of Pemetrexed With or Without Either Bevacizumab or Pembrolizumab in Patients With Metastatic NSCLC

Autor:	Kwok, W.C., Cheong, T.F., Chiang, K.Y., Ho, C.M.J., Lam, C.L.D., Ip, M.S.M., Tam, C.C.T.
Zdroj:	In Journal of Thoracic Oncology March 2021 16(3) Supplement:S130-S130
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu